Creatinine Blood Test: Normal Ranges & Causes | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Creatinine blood test

Creatinine (serum). Also called: Serum creatinine, SCr, Cr

Biomarker guideLast updated: October 29, 2026

Creatinine is a waste product of muscle that the kidneys filter out of the blood. A rise usually means the kidneys are filtering less, but muscle mass, a cooked-meat meal, hard exercise, creatine supplements and some drugs can raise it with healthy kidneys.

LOINC 2160-0Kidney

At a glance

What it measuresCreatinine, a waste product made from muscle at a fairly steady rate and cleared by the kidneys.
SampleBlood (serum or heparin plasma). No fasting is listed, but a cooked-meat meal on the day of the test can raise it.
Typical adult rangeLabcorp: women 0.57-1.00 mg/dL, men 0.76-1.27 mg/dL. Quest, ages 18-29: women 0.50-0.96, men 0.60-1.24 mg/dL.
Common reasons it reads highReduced kidney function, dehydration, a cooked-meat meal, hard exercise, creatine supplements, high muscle mass, trimethoprim and some other drugs.
Peptides that move itRaised by the kidney-toxic antibiotics Colistin and Polymyxin B. Lowered in hepatorenal syndrome by Terlipressin. No change with Lixisenatide in a large trial.
Lab codeLOINC 2160-0 (Labcorp 001370, Quest 375)

What is Creatinine?

Creatinine is a waste product of muscle: how much a person makes each day tracks their muscle mass. The kidneys filter it out of the blood and the kidney tubules also secrete some, so its blood level rises when kidney filtering falls.

It is the most widely used blood index of kidney function, and the basis of the estimated glomerular filtration rate (eGFR). At Labcorp and Quest a creatinine order includes an eGFR.

Sources: [1] [2] [3] [4] [5]

How it is made and regulated

Where it is made

Daily creatinine output follows skeletal muscle mass: in 466 men, 1 g of creatinine in 24-hour urine corresponded to 22.73 kg of muscle. Diet adds to it; a cooked-meat meal raised serum creatinine within 1-2 hours.

Sources: [1] [6]

What controls it

The blood level is set by how fast creatinine is made and how fast the kidneys remove it. Removal is mostly by filtration, but the tubules secrete it too, and the balance shifts with hydration: the ratio of creatinine to inulin clearance ranged from 1.47 when well hydrated to 1.05 when dehydrated.

Sources: [2]

How it travels in the blood

Tubular secretion runs through cation transporters such as OCT2. Drugs that block them, such as trimethoprim and dolutegravir, raise serum creatinine without lowering the true filtration rate.

Sources: [7] [8] [9]

How long it lasts

In healthy young men creatinine has a half-life of about 3.85 hours, stretching to 77 hours when kidney function falls to 5% of normal. After a sudden change in kidney function it takes days to settle: about 1.1 days to reach 95% of the new level at half of normal function, and 13.4 days at 5%.

Sources: [10]

What it does

Creatinine matters as a marker. Labcorp notes that it becomes abnormal only when about half or more of the nephrons have stopped working in chronic kidney disease, and Quest that a result in the reference range does not rule out impaired kidney function.

Sources: [4] [5]

Reference ranges

Creatinine is higher in men and in adults than in children, because it tracks muscle mass. Labcorp gives one range for both sexes until age 15; Quest gives ranges by decade. Use the range printed on your report.

Labcorp (test 001370)

Method: Kinetic Jaffe. Labcorp test page (retrieved October 29, 2026).

GroupRange (mg/dL)
Females, 15 years and older0.57-1.00
Males, 15 years and older0.76-1.27
Children and teens
GroupRange (mg/dL)
Infants, under 2 months0.44-1.19
Infants, 2 to 11 months0.17-1.18
Children, 1 to under 3 years0.19-0.42
Children, 3 to under 5 years0.26-0.51
Children, 5 to under 7 years0.30-0.59
Children, 7 to under 9 years0.37-0.62
Children, 9 to under 11 years0.39-0.70
Children, 11 to under 13 years0.42-0.75
Teens, 13 to under 15 years0.49-0.90

Labcorp internal studies. Includes an eGFR calculation (CKD-EPI 2021, no race coefficient).

Quest Diagnostics (test 375)

Method: Spectrophotometry (SP). Quest Diagnostics test page (retrieved October 29, 2026).

GroupRange (mg/dL)
Males, 18 to 29 years0.60-1.24
Females, 18 to 29 years0.50-0.96
Males, 30 to 39 years0.60-1.26
Females, 30 to 39 years0.50-0.97
Males, 40 to 49 years0.60-1.29
Females, 40 to 49 years0.50-0.99
Males, 50 to 59 years0.70-1.30
Females, 50 to 59 years0.50-1.03
Males, 60 to 69 years0.70-1.35
Females, 60 to 69 years0.50-1.05
Males, 70 to 79 years0.70-1.28
Females, 70 to 79 years0.60-1.00
Males, 80 years and older0.70-1.22
Females, 80 years and older0.60-0.95
Children and teens
GroupRange (mg/dL)
All, 2 days or younger0.79-1.58
All, 3 to 27 days0.35-1.23
All, 1 month to 9 years0.20-0.73
All, 10 to 12 years0.30-0.78
Males, 13 to 15 years0.40-1.05
Females, 13 to 15 years0.40-1.00
Males, 16 to 17 years0.60-1.20
Females, 16 to 17 years0.50-1.00

Ranges as shown for Quest's East region. Quest's table adds: "For patients >49 years of age, the upper reference limit for creatinine is approximately 13% higher for people identified as African-American."

Quest's table still carries a note that for patients over 49 the upper limit is about 13% higher for people identified as African-American. Both labs report eGFR with the race-free CKD-EPI 2021 equation.

Units: Labs outside the US report creatinine in µmol/L: 1.5 mg/dL is about 133 µmol/L. [13]

Sources: [4] [5] [11] [12]

What raises it

FactorHowHow much
Reduced kidney functionConditionKidney disease, a blocked urinary tract and reduced blood flow to the kidneys (heart failure, shock, dehydration) all lower filtration and raise creatinine. Rhabdomyolysis raises it too.No published magnitude [4]
A cooked-meat mealNutritionEating cooked meat raises serum creatinine for several hours; a meat-free meal had little effect. Cystatin C was not affected.Median 80.5 to 101.0 µmol/L 1-2 hours after the meal; eGFR fell from 84.0 to 59.5 [6] [14]
Hard exerciseLifestyleSerum creatinine rose after intense resistance exercise, and the fall in eGFR tracked the rise in the muscle-damage marker CK.Up 31.3% in men and 29.8% in women after one resistance-exercise session (measured over 24-72 hours) [15]
Creatine supplementsNutritionCreatine ethyl ester raised serum creatinine to a level that mimicked kidney failure in one case, with normal kidney function; it reversed after the supplement was stopped.No published magnitude [16]
High muscle massPhysiologyMore muscle makes more creatinine, so muscular people run higher. Creatinine-based eGFR is least accurate at the extremes of muscle mass.1 g of daily urinary creatinine for every 22.73 kg of skeletal muscle [1] [12]
Drugs that block creatinine secretionMedicationTrimethoprim (in co-trimoxazole) and dolutegravir block tubular secretion, raising creatinine while measured GFR stays the same. The rise is reversible.Trimethoprim-sulfamethoxazole raised serum creatinine by an average of 2 mg per liter in 21 patients, starting within 4 hours; dolutegravir lowered creatinine clearance by 10-14% [7] [8] [9]
FenofibrateMedicationFenofibrate raises creatinine in some people; in the ACCORD trial the rise was fully reversed 51 days after stopping, and cystatin C moved in parallel.A rise of 20% or more within 3 months of starting in 321 participants [17]
Assay interference and delayed processingPhysiologyThe Jaffe method also reacts with cephalosporin antibiotics, high glucose, pyruvate and bilirubin, and reads high at low concentrations. Blood left unspun for 24 hours gave higher Jaffe results; enzymatic methods were stable.Glucose above 450 mg/dL: +16% (Labcorp); Jaffe methods read 21% high at a true value of 52 µmol/L in Dutch quality testing [4] [18] [19] [20]
Kidney-toxic peptide antibioticsPeptideColistin and polymyxin B can injure the kidney, raising BUN and creatinine; the damage is dose-dependent and usually reversible. See the peptide table below.IV colistin for 4 weeks or more: median creatinine up 0.25 mg/dL [21] [22]

What lowers it

FactorHowHow much
Low muscle massPhysiologySmall stature, frailty and muscle loss mean less creatinine is made. A low creatinine then makes creatinine-based eGFR read falsely high.No published magnitude [4] [12]
Advanced liver diseaseConditionLess creatinine is produced because of reduced liver production, poor protein intake and muscle loss.No published magnitude [4]
PregnancyPhysiologyKidney filtration rises 40-65% in normal pregnancy, so creatinine falls. It rises slightly again near term.Healthy ranges 0.42-0.75 mg/dL (first trimester), 0.38-0.71 (second) and 0.39-0.75 (third) [23] [24]
Very high vitamin C in the sampleNutritionAscorbic acid interferes with the creatinine test.Ascorbic acid above 88 mg/dL: -10.1% (Labcorp) [4] [18]
Treating hepatorenal syndromePeptideTerlipressin, a vasopressin analog approved for hepatorenal syndrome (kidney failure caused by advanced liver disease), brought creatinine down more often than placebo. See the peptide table below.Verified hepatorenal-syndrome reversal (two creatinine values of 1.5 mg/dL or below) in 29.1% vs 15.8% with placebo [25]

Peptides that affect Creatinine

How each peptide in our library has been shown to affect serum creatinine, strongest evidence first. Rises mostly come from drug labels and kidney-toxic antibiotics; falls mostly come from kidney-injury models. "No clear effect" means creatinine was measured and did not change.

PeptideEffect on CreatinineSize of effectEvidence
VasopressinRaisesRetrospective, 117 children in advanced vasodilatory shock: urea and creatinine rose with longer duration/higher cumulative dose; reversibleIn critically ill children, creatinine rose with longer or higher-dose infusions and recovered afterwards. [26]Human trials
Atrial Natriuretic PeptideLowersMeta-analysis of cardiovascular surgery patients: ANP (carperitide) infusion significantly decreased peak serum creatinineLowered post-surgery creatinine rises in heart-surgery patients (Japanese carperitide data). [27]Human trials
Human Relaxin-2LowersRELAX-AHF-2 biomarker substudy (n=1,020), 48-hour IV serelaxin: creatinine -0.8% vs +5.8% placebo at day 2 (P=0.002)In acute heart failure, serelaxin blunted the early creatinine rise; the effect faded after day 2. [28]Human trials
LiraglutideLowersMeta-analysis of 18 RCTs, 1580 people with type 2 diabetic nephropathy: serum creatinine SMD -0.81 (95% CI -1.22 to -0.40) vs no liraglutidePooled, mostly small trials in diabetic kidney disease; a standardized difference, not a fixed mg/dL change. [29]Human trials
SS-31LowersPhase 2a, atherosclerotic renal artery stenosis, single 0.05 mg/kg/h IV infusion during stenting (n=6 vs 8 placebo): creatinine 1.58 to 1.4 mg/dL at 3 months (P=0.0005); placebo unchangedSmall pilot: given around a kidney-artery stent procedure, creatinine fell over 3 months. Not a test of routine use. [30]Human trials
Adrenocorticotropic Hormone (ACTH)No clear effectAdvanced diabetic nephropathy, ACTH gel 16 units: mean creatinine 2.5 → 2.8 → 2.9 mg/dL from baseline to 6 months on treatment and 6-12 months after (P = 0.826)In a small pilot study of advanced diabetic kidney disease, creatinine did not change significantly. [31]Human trials
Angiotensin 1-7No clear effectCOVID-19 pilot RCT (TXA-127): AKI by KDIGO creatinine criteria in 3 treated vs 1 placebo patient; no difference, and the study was underpoweredNo kidney signal in a small COVID-19 pilot trial; it was underpowered and cannot rule an effect in or out. [32]Human trials
BivalirudinNo clear effectMATRIX trial, acute coronary syndrome: creatinine-defined AKI in 16.9% with bivalirudin vs 17.4% with heparin (OR 0.97, P = 0.58)In a large randomized trial, bivalirudin did not change the rate of creatinine-defined kidney injury versus heparin. [33]Human trials
CarnosineNo clear effectType 2 diabetic nephropathy RCT, 12 weeks of oral carnosine: serum creatinine unchanged; NEAT (2 g/day) also found no effect on kidney functionOral carnosine did not change creatinine in two placebo-controlled trials. [34] [35]Human trials
DesmopressinNo clear effectNo difference in serum creatinine at 24 hours vs saline after 0.3 µg/kg after gastrointestinal surgery (59 patients)Short-term surgical trial; the main safety issue with desmopressin is low sodium, not kidney injury. [36]Human trials
EnfuvirtideNo clear effectCreatinine 1.11 to 1.15 mg/dL (p = 0.194) with 90 mg twice daily for 7 days in 12 healthy men (crossover vs placebo)No creatinine change in a short healthy-volunteer study. [37]Human trials
Erythropoietin (EPO)No clear effectHigh-dose epoetin alfa given into the artery at kidney-graft reperfusion: 1-month renal function similar to placebo (72 deceased-donor transplant recipients)Did not improve or worsen early graft function. [38]Human trials
LixisenatideNo clear effectELIXA (6068 people with type 2 diabetes after acute coronary syndrome randomized, 10-20 µg daily, median 108 weeks): creatinine doubling 41/3031 vs 35/3032 placebo (HR 1.163, p = 0.51)Lixisenatide did not raise the risk of creatinine doubling in a large outcome trial. [39]Human trials
Parathyroid Hormone-Related Peptide (PTHrP)No clear effect7-day continuous IV infusion of PTHrP(1-36) in healthy adults (maximum tolerated 4 pmol/kg/h): no significant effect on serum creatinineLow-dose PTHrP infusion did not change creatinine in healthy volunteers (data not shown in the paper). [40]Human trials
ColistinRaisesFDA label: dose-dependent nephrotoxicity with rising BUN and creatinine, reversible on stopping; IV colistin over 4+ weeks raised median creatinine by 0.25 mg/dL (p < 0.001)A well-known cause of kidney injury; creatinine is monitored during treatment. [21] [22]FDA label
ExenatideRaisesPostmarketing reports of altered renal function including increased serum creatinine and acute renal failure (sometimes requiring dialysis); no trial incidence givenRare reports, mostly linked to dehydration from nausea or vomiting. [41]FDA label
LeuprolideRaisesLupron Depot 7.5 mg monthly trials (prostate cancer): increased creatinine recorded in at least 5% of patients at final visitA label lab finding in older men with prostate cancer; no controlled kidney-function data. [42]FDA label
NesiritideRaisesASCEND-HF (acute heart failure): creatinine >50% above baseline at 30 days in 4.6% vs 3.3% placebo; PRECEDENT: rise >0.5 mg/dL by day 14 in 17-19% vs 11%The label warns nesiritide may worsen kidney function as judged by serum creatinine; monitor during and after infusion. [43]FDA label
OctreotideRaisesMycapssa label, postmarketing octreotide reports: "creatinine increased" (no frequency)A postmarketing report category, not a trial finding. [44]FDA label
Polymyxin BRaisesBoxed warning: nephrotoxicity with azotemia; in a cohort, abnormal or doubled serum creatinine in 6/41 (14.6%) on polymyxin BKidney toxicity is a boxed warning; creatinine should be followed during treatment. [45] [46]FDA label
TerlipressinLowersCONFIRM trial, hepatorenal syndrome: 2 consecutive SCr <=1.5 mg/dL (verified HRS reversal) in 58/199 (29.1%) vs 16/101 (15.8%) placebo, P=0.012In hepatorenal syndrome (kidney failure from cirrhosis), terlipressin brought creatinine back down more often than placebo. [25]FDA label
IGF-1 (Insulin-Like Growth Factor 1)No clear effectIncrelex children: serum creatinine normal in all despite kidney growth; ARF trial (n=72), rhIGF-I 100 ug/kg SC every 12 h: no difference vs placebo in creatinine changeCreatinine stayed normal in treated children, and IGF-1 did not change creatinine in a kidney-failure trial. [47] [48]FDA label
Parathyroid Hormone (PTH)No clear effectTeriparatide (Forteo) osteoporosis trials: serum creatinine, BUN and creatinine clearance assessed; no clinically important adverse renal effectsData are from the teriparatide (Forteo) trials: creatinine was measured and showed no clinically important kidney effects. The same label is the source for the teriparatide entry. [49]FDA label
TeriparatideNo clear effectForteo clinical studies: serum creatinine measured, no clinically important adverse renal effectsLabel reports no clinically important kidney effects; serum creatinine was among the tests checked. [49]FDA label
AdipotideRaisesObese rhesus monkeys: slight-to-moderate dose-dependent creatinine rises at subcutaneous doses above 0.25 mg/kg, falling during recoveryAdipotide raised creatinine in monkeys (kidney toxicity was the main safety signal). Never tested in humans. [50]Animal studies
AdrenomedullinLowersRats with renal ischemia-reperfusion: human AM plus AMBP-1 lowered serum creatinine by 64% and BUN by 47% at 24 hShown only for adrenomedullin given together with its binding protein, in rats. [51]Animal studies
Alpha-Melanocyte-Stimulating Hormone (α-MSH)LowersMice and rats with renal ischemia: alpha-MSH reduced the rise in plasma creatinine and BUN (no number given in the abstract)Protected the kidney after ischemic injury in rodents. No human data. [52]Animal studies
ARA-290LowersRats with renal ischemia-reperfusion: ARA-290 at 1 h after reperfusion lowered serum creatinine at day 3; later or repeated dosing did notProtected kidney function in rats only when given early. No human data. [53]Animal studies
FOXO4-DRILowersPlasma creatinine reduced 30 days after 3 × 5 mg/kg i.p. (every other day) in naturally aged (110+ week) miceMouse ageing study; senescent-cell clearance improved kidney filtering. No human data. [54]Animal studies
GHRP-6LowersSerum creatinine significantly lower than control at 3 and 7 days with a GHRP-6 hydrogel after ischemic acute kidney injury in miceMouse kidney-injury model using a gel form of the peptide. [55]Animal studies
HexarelinLowersSerum creatinine rise after kidney ischemia-reperfusion significantly reduced by 100 µg/kg/day for 7 days beforehand in rats (P < 0.05)Rat acute kidney injury model only. [56]Animal studies
IntermedinLowersRat contrast-induced acute kidney injury (iohexol), n=6/group: serum creatinine notably lower with intermedin than iohexol aloneRat study only: intermedin limited the creatinine rise after contrast dye. [57]Animal studies
Orexin ALowersCisplatin kidney injury in mice: creatinine 1.46 ± 0.24 mg/dL with cisplatin vs 0.64 ± 0.09 mg/dL with cisplatin + orexin A IP (p < 0.01)Protected against a raised creatinine in a mouse kidney-injury model; no human data. [58]Animal studies
CapromorelinNo clear effectInappetent dogs, 3 mg/kg daily for 4 days (veterinary RCT, 171 treated vs 73 placebo): mean creatinine change similar between groupsNo creatinine effect at the approved veterinary dose in dogs. Capromorelin is not a human drug. [59]Animal studies
HumaninNo clear effectApoE-deficient and C57BL/6 mice on high-cholesterol diet treated with humanin: serum creatinine comparable among groupsMouse study only: humanin did not change serum creatinine. [60]Animal studies

What high or low results can mean

A high result

A high creatinine usually means the kidneys are filtering less, but it can also come from a lot of muscle, a meat meal, hard exercise, creatine supplements or drugs that block creatinine secretion.

  • Chronic kidney disease or acute kidney injury
  • Dehydration, heart failure or shock
  • Blocked urinary tract
  • A cooked-meat meal or hard exercise before the test
  • High muscle mass or creatine supplements
  • Trimethoprim, dolutegravir, fenofibrate
  • Rhabdomyolysis

Next step: Discuss it with a clinician. A repeat test after avoiding cooked meat and hard exercise, a medication review, and an eGFR with urine albumin usually come first; cystatin C helps when muscle mass is unusual.

Sources: [4] [6] [15] [12] [61]

A low result

A low creatinine usually reflects low muscle mass rather than a kidney problem.

  • Low muscle mass, small stature or frailty
  • Advanced liver disease
  • Pregnancy

Next step: Usually no action is needed. Low muscle makes creatinine-based eGFR read high, so a cystatin C test can give a truer picture of kidney function.

Sources: [4] [12] [61] [24]

How the test works

SampleSerum (preferred) or lithium-heparin plasma at Labcorp, separated within 45 minutes; oxalate, EDTA and citrate plasma are not accepted, and hemolyzed samples are rejected. Quest prefers 1 mL of serum, accepts sodium or lithium heparin plasma, and rejects grossly icteric samples.
FastingNeither lab requires fasting, but a cooked-meat meal can raise creatinine within 1-2 hours, so a fasting sample, or one taken on a day without cooked meat, is more reliable.
TimingAvoid hard exercise for a few days beforehand: one resistance-exercise session raised creatinine by about 30% over the next 24-72 hours. Labcorp notes that cephalosporin antibiotics can falsely raise results if blood is drawn within four hours of a dose.
Lab differencesLabcorp uses the kinetic Jaffe method; Quest lists spectrophotometry. Jaffe methods react with other substances and read higher than enzymatic methods at low concentrations. A 2006 national program recommended calibrating all methods to a reference method (isotope-dilution mass spectrometry), but calibration does not remove interferences.
RetestingCreatinine varies less than many tests: within-person variation was 4.2-4.5% over four weeks in healthy adults, and two results need to differ by about 13.43-14.26% before the change is likely to be real.
Labcorp order code001370: Creatinine (includes eGFR)
Quest Diagnostics order code375: Creatinine (includes eGFR)
LOINC codes
  • 2160-0: Creatinine [Mass/volume] in Serum or Plasma
  • 14682-9: Creatinine [Moles/volume] in Serum or Plasma (reported in µmol/L)
  • 38483-4: Creatinine [Mass/volume] in Blood (whole blood)
LOINC 2160-0 on loinc.org

Sources: [4] [5] [62] [6] [63] [15] [20] [13] [64]

History

Most labs still measure creatinine with a reaction first described in 1886. By the 1970s serum creatinine was being turned into formulas for kidney function, and the effects of muscle, diet and drugs on it were becoming clear.

  1. 1886Max Jaffe describes the reaction of creatinine with picric acid in alkaline solution, the basis of the "Jaffe" method later developed by Otto Folin. [65]
  2. 1975Trimethoprim-sulfamethoxazole is shown to raise serum creatinine without changing measured filtration, by competing with its secretion. [7]
  3. 1976Cockcroft and Gault publish a formula predicting creatinine clearance from serum creatinine, age and weight (15% lower in women), derived from 249 patients aged 18-92. [66]
  4. 1988A study in healthy volunteers shows extensive tubular secretion and reabsorption of creatinine that changes with hydration, making creatinine clearance an unreliable measure of GFR. [2]
  5. 2006The US National Kidney Disease Education Program recommends standardizing serum creatinine measurement for GFR estimation. [13]
  6. 2012Dutch quality-control data show Jaffe methods overestimating low creatinine values; the authors argue labs should move to enzymatic methods. [20]

FAQ

Do I need to fast before a creatinine test?

Neither Labcorp nor Quest requires fasting. But a cooked-meat meal can raise creatinine within 1-2 hours, so a fasting sample or one taken on a day without cooked meat gives a truer result.

Sources: [4] [5] [6] [63]

Can eating meat raise my creatinine?

Yes. In 32 people, a cooked-meat meal raised median creatinine from 80.5 to 101.0 µmol/L within 1-2 hours, enough to drop eGFR from 84.0 to 59.5 and misclassify kidney disease. A meat-free meal had little effect.

Sources: [6]

Can exercise raise creatinine?

Yes. After one resistance-exercise session, serum creatinine rose 31.3% in men and 29.8% in women over the following days, and eGFR fell by about 8-10%.

Sources: [15]

Do creatine supplements raise creatinine?

They can. In one reported case creatine ethyl ester raised creatinine to a level that looked like kidney failure, with normal kidneys; it reversed after the supplement was stopped. Tell your clinician if you take creatine.

Sources: [16]

What is a normal creatinine level?

For adults, Labcorp's range is 0.57-1.00 mg/dL for women and 0.76-1.27 mg/dL for men. Quest's ranges change by decade, for example 0.50-0.96 mg/dL for women and 0.60-1.24 mg/dL for men aged 18-29.

Sources: [4] [5]

Why is my creatinine high if my kidneys are fine?

Creatinine also reflects muscle, diet and drugs. High muscle mass, a meat meal, hard exercise and creatine raise it, and trimethoprim and dolutegravir block its secretion, raising it while true filtration stays the same.

Sources: [1] [6] [7] [8]

What does a low creatinine mean?

Usually low muscle mass, from small stature, frailty or illness, and sometimes advanced liver disease or pregnancy. It is rarely a problem by itself, but it can make eGFR look better than kidney function really is.

Sources: [4] [12] [24]

How is creatinine related to eGFR?

Labs put serum creatinine, age and sex into an equation to estimate the glomerular filtration rate. Labcorp and Quest both use the CKD-EPI 2021 equation, which does not use race, and report eGFR with every creatinine.

Sources: [12] [11] [5]

Can peptides affect creatinine?

The peptide antibiotics Colistin and Polymyxin B can damage the kidneys and raise creatinine, and the Nesiritide label warns it may worsen kidney function. Terlipressin lowered creatinine in hepatorenal syndrome, and Lixisenatide did not raise the risk of creatinine doubling in a large trial.

Sources: [21] [45] [43] [25] [39]

Does creatinine change in pregnancy?

Yes, it falls. Kidney filtration rises by 40-65%, and healthy pregnancy ranges in a UK study were 0.42-0.75 mg/dL in the first trimester, 0.38-0.71 in the second and 0.39-0.75 in the third.

Sources: [23] [24]

Why does Quest's range mention race?

Quest's table still notes that for patients over 49 the upper creatinine limit is about 13% higher for people identified as African-American. Its eGFR no longer uses race: since July 11, 2022 Quest has used the race-free 2021 equation, whose authors called race in eGFR equations a social and not a biologic construct.

Sources: [5] [11] [67]

How much does creatinine vary between tests?

Not much compared with many tests: within-person variation was 4.2-4.5% over four weeks in healthy adults. A change of more than about 13.43-14.26% between two results is likely to be real.

Sources: [64]

References

  1. Iacone R, D'Elia L, Guida B, et al. Validation of daily urinary creatinine excretion measurement by muscle-creatinine equivalence. J Clin Lab Anal. 2018;32(6):e22407. PMID 29424044
  2. Sjöström PA, Odlind BG, Wolgast M. Extensive tubular secretion and reabsorption of creatinine in humans. Scand J Urol Nephrol. 1988;22(2):129-31. PMID 3206217
  3. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-70. PMID 10075613
  4. Labcorp. Test 001370: Creatinine. Methodology, use, limitations, interfering substances, reference intervals and LOINC map. labcorp.com/tests/001370/creatinine
  5. Quest Diagnostics. Test code 375: Creatinine (includes eGFR). Test directory entry (East region): methodology, specimen, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/375/creatinine?cc=PHP
  6. Preiss DJ, Godber IM, Lamb EJ, et al. The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem. 2007;44(Pt 1):35-42. PMID 17270090
  7. Berglund F, Killander J, Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol. 1975;114(6):802-8. PMID 1195454
  8. Koteff J, Borland J, Chen S, et al. A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects. Br J Clin Pharmacol. 2013;75(4):990-6. PMID 22905856
  9. Delanaye P, Mariat C, Cavalier E, et al. Trimethoprim, creatinine and creatinine-based equations. Nephron Clin Pract. 2011;119(3):c187-93; discussion c193-4. PMID 21832843
  10. Chiou WL, Hsu FH. Pharmacokinetics of creatinine in man and its implications in the monitoring of renal function and in dosage regimen modifications in patients with renal insufficiency. J Clin Pharmacol. 1975;15(5-6):427-34. PMID 1133219
  11. Quest Diagnostics. Test changes effective 7/11/2022: transition of eGFR reporting to the 2021 race-free (CKD-EPI 2021cr) equation (IntelliTest Manager notice 232586). intellitestmanager.questdiagnostics.com/home/output/232586
  12. Labcorp. Test 100768: Glomerular Filtration Rate, Estimated (eGFR). Equation, limitations, GFR categories, reference interval and LOINC map. labcorp.com/tests/100768/glomerular-filtration-rate-estimated-egfr
  13. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52(1):5-18. PMID 16332993
  14. Hilderink JM, van der Linden N, Kimenai DM, et al. Biological Variation of Creatinine, Cystatin C, and eGFR over 24 Hours. Clin Chem. 2018;64(5):851-860. PMID 29483105
  15. Amorim MZ, Machado M, Hackney AC, et al. Sex differences in serum CK activity but not in glomerular filtration rate after resistance exercise: is there a sex dependent renal adaptative response?. J Physiol Sci. 2014;64(1):31-6. PMID 24037727
  16. Williamson L, New D. How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology. BMJ Case Rep. 2014;2014. PMID 25239988
  17. Mychaleckyj JC, Craven T, Nayak U, et al. Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants. Diabetes Care. 2012;35(5):1008-14. PMID 22432114
  18. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem. 1991;37(5):695-700. PMID 2032322
  19. Shepherd J, Warner MH, Kilpatrick ES. Stability of creatinine with delayed separation of whole blood and implications for eGFR. Ann Clin Biochem. 2007;44(Pt 4):384-7. PMID 17594786
  20. Drion I, Cobbaert C, Groenier KH, et al. Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol. 2012;13:133. PMID 23043743
  21. COLY-MYCIN M Parenteral (colistimethate for injection), prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d6e13e2-dc33-4b7b-84d0-66146a57c552
  22. Falagas ME, Rizos M, Bliziotis IA, et al. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis. 2005;5:1. PMID 15642116
  23. Jeyabalan A, Conrad KP. Renal function during normal pregnancy and preeclampsia. Front Biosci. 2007;12:2425-37. PMID 17127252
  24. Skinner L, Birnie K, Mettam KA, et al. Defining normal serum creatinine in pregnancy-results from the AKID UK prospective cohort study. Clin Kidney J. 2025;18(2):sfae418. PMID 40235627
  25. TERLIVAZ (terlipressin) for injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354
  26. Jerath N, Frndova H, McCrindle BW, et al. Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients. Intensive Care Med. 2008;34(7):1274-80. PMID 18350274
  27. Mitaka C, Kudo T, Haraguchi G, et al. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care. 2011;15(5):R258. PMID 22032777
  28. Voors AA, Metra M, Postmus D, et al. End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2). Eur J Heart Fail. 2025;27(7):1215-1223. PMID 39663924
  29. Mali N, Su F, Ge J, et al. Efficacy of liraglutide in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. BMC Endocr Disord. 2022;22(1):93. PMID 35392872
  30. Saad A, Herrmann SMS, Eirin A, et al. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis. Circ Cardiovasc Interv. 2017;10(9). PMID 28916603
  31. Tumlin JA, Galphin CM, Rovin BH. Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1. J Diabetes Res. 2013;2013:489869. PMID 24159603
  32. Wagener G, Goldklang MP, Gerber A, et al. A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19. Crit Care. 2022;26(1):229. PMID 35902867
  33. Landi A, Branca M, Andò G, et al. Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial. Eur Heart J Acute Cardiovasc Care. 2021;10(10):1170-1179. PMID 34491323
  34. Siriwattanasit N, Satirapoj B, Supasyndh O. Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial. BMC Nephrol. 2021;22(1):236. PMID 34174842
  35. Baba SP, Amraotkar AR, Hoetker D, et al. Evaluation of supplementary carnosine accumulation and distribution: an initial analysis of participants in the Nucleophilic Defense Against PM Toxicity (NEAT) clinical trial. Amino Acids. 2024;56(1):55. PMID 39215872
  36. Wang LC, Hu YF, Chen L, et al. Desmopressin acetate decreases blood loss in patients with massive hemorrhage undergoing gastrointestinal surgery. Turk J Gastroenterol. 2020;31(6):474-481. PMID 32721919
  37. Barroso S, Morén C, González-Segura À, et al. Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers. PLoS One. 2019;14(5):e0216712. PMID 31120908
  38. Sureshkumar KK, Hussain SM, Ko TY, et al. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin J Am Soc Nephrol. 2012;7(9):1498-506. PMID 22745272
  39. Muskiet MHA, Tonneijck L, Huang Y, et al. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2018;6(11):859-869. PMID 30292589
  40. Horwitz MJ, Tedesco MB, Sereika SM, et al. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J Bone Miner Res. 2011;26(9):2287-97. PMID 21544866
  41. BYETTA (exenatide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f
  42. LUPRON DEPOT (leuprolide acetate for depot suspension), prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd
  43. NATRECOR (nesiritide) for injection, prescribing information, revised 01/2019. U.S. Food and Drug Administration. accessdata.fda.gov/drugsatfda_docs/label/2019/020920s036lbl.pdf
  44. MYCAPSSA (octreotide) delayed-release capsules, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58d80bc6-bdfb-4908-93e7-aace447c8d1a
  45. Polymyxin B for Injection USP, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2bf65f6-2763-4859-a665-ad5e6cde71ee
  46. Wang J, Shah BK, Zhao J, et al. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB. BMC Infect Dis. 2023;23(1):351. PMID 37231342
  47. INCRELEX (mecasermin) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce
  48. Hirschberg R, Kopple J, Lipsett P, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999;55(6):2423-32. PMID 10354291
  49. FORTEO (teriparatide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0
  50. Barnhart KF, Christianson DR, Hanley PW, et al. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med. 2011;3(108):108ra112. PMID 22072637
  51. Shah KG, Rajan D, Jacob A, et al. Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein. J Surg Res. 2010;163(1):110-7. PMID 20538296
  52. Chiao H, Kohda Y, McLeroy P, et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest. 1997;99(6):1165-72. PMID 9077523
  53. van Rijt WG, Nieuwenhuijs-Moeke GJ, van Goor H, et al. Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury. J Transl Med. 2013;11:286. PMID 24225194
  54. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;169(1):132-147.e16. PMID 28340339
  55. Zhao X, Pan K, Li R, et al. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation. J Nanobiotechnology. 2025;24(1):15. PMID 41327290
  56. Guan C, Li C, Shen X, et al. Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. Eur J Med Res. 2023;28(1):344. PMID 37710348
  57. Gao T, Gu R, Wang H, et al. The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway. Int J Mol Sci. 2024;25(20). PMID 39456892
  58. Jo J, Kim JY, Leem J. Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury. J Clin Med. 2022;11(23). PMID 36498769
  59. Zollers B, Wofford JA, Heinen E, et al. A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite. J Vet Intern Med. 2016;30(6):1851-1857. PMID 27859746
  60. Zhang X, Urbieta-Caceres VH, Eirin A, et al. Humanin prevents intra-renal microvascular remodeling and inflammation in hypercholesterolemic ApoE deficient mice. Life Sci. 2012;91(5-6):199-206. PMID 22820173
  61. Awdishu L, Karger AB, Shlipak MG, et al. Use of Cystatin C in Tandem with Creatinine to Improve GFR Estimation and Clinical Decision Making. J Am Soc Nephrol. 2026;37(9):2042-2054. PMID 42424121
  62. LOINC 2160-0: Creatinine [Mass/volume] in Serum or Plasma. Regenstrief Institute. Record checked through the NLM Clinical Table Search Service. loinc.org/2160-0
  63. Pimenta E, Jensen M, Jung D, et al. Effect of Diet on Serum Creatinine in Healthy Subjects During a Phase I Study. J Clin Med Res. 2016;8(11):836-839. PMID 27738487
  64. Mercan H, Orhan B, Bercik-Inal B. Estimation of Reference Change Value and Biological Variation of Creatinine Measurements in Healthy Individuals. Clin Lab. 2022;68(9). PMID 36125155
  65. Delanghe JR, Speeckaert MM. Creatinine determination according to Jaffe-what does it stand for?. NDT Plus. 2011;4(2):83-6. PMID 25984118
  66. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. PMID 1244564
  67. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. PMID 34554658

Educational information, not medical advice. Lab ranges and test codes were checked on October 29, 2026. Always use the range printed on your own report, and talk to a clinician about your results.